Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BioCapInvest, LLC is a life sciences seed-financing venture capital firm founded by Cyrus A. Chowdhury. Established in the United States, the firm is dedicated to supporting early-stage biopharmaceutical and digital health companies by providing seed capital to advance their development programs. The firm operates with a clear mission to address unmet patient needs through innovative solutions in the healthcare sector.
With a focus on seed-stage investments, BioCapInvest collaborates with both individual and institutional investors to finance groundbreaking technologies. The firm is particularly interested in areas such as gene therapy, cell therapy, AI/ML-driven therapeutics, and digital health solutions. BioCapInvest's commitment to the life sciences sector is underscored by its founder's extensive experience, which spans over 20 years in various roles including financial, commercial strategy, clinical, and health policy functions.
Headquartered in the United States, BioCapInvest is positioned to leverage its founder's background and connections within the healthcare ecosystem. The firm has exhibited at significant industry events, such as the BIO CEO & Investor Conference 2025, highlighting its active engagement with the life sciences investment community.
BioCapInvest invests primarily in early-stage biopharmaceutical and digital health assets. The firm targets innovative technologies that include gene therapy, cell therapy, AI/ML-driven therapeutics, and digital health solutions. This focus aligns with BioCapInvest's mission to support entrepreneurs who are addressing unmet patient needs and advancing their development programs.
The firm seeks to identify and finance entrepreneurs at the development frontier of these technologies. BioCapInvest's investment strategy emphasizes collaboration with both individual and institutional investors, ensuring that portfolio companies receive not only capital but also strategic guidance. The firm values partnerships that enhance the potential for successful market entry and patient impact.
In terms of deal structure, BioCapInvest typically engages in seed financing, which allows it to support companies at their earliest stages. This approach enables the firm to play a crucial role in the growth of innovative therapeutic and technological solutions within the healthcare sector.
BioCapInvest has not publicly disclosed specific portfolio companies. However, the firm focuses on early-stage biopharmaceutical and digital health companies, particularly those involved in:
While no notable exits or current portfolio companies are mentioned, BioCapInvest's investment strategy is centered on supporting entrepreneurs who are developing groundbreaking therapies and technologies. The firm aims to facilitate advancements that can significantly improve patient outcomes.
Cyrus A. Chowdhury - Managing Director. Cyrus has over 20 years of experience in the life sciences sector, encompassing roles in financial, commercial strategy, clinical, and health policy functions. Prior to founding BioCapInvest, he founded and led CBPartners, a life sciences commercial strategy consulting firm, for seven years as Managing Director and CEO.
To pitch to BioCapInvest, founders should send an email to cyrus.chowdhury@biocapinvest.com. It is recommended to include a comprehensive pitch deck that outlines the business model, technology, market potential, and team background.
While specific response time expectations are not disclosed, founders should anticipate a thorough review process. Warm introductions may enhance the likelihood of receiving a timely response, so leveraging connections within the life sciences community could be beneficial.
BioCapInvest exhibited at the BIO CEO & Investor Conference 2025, indicating its active engagement with the institutional life sciences investment community. This participation highlights the firm's commitment to connecting with potential partners and investors in the healthcare sector.
What are BioCapInvest's investment criteria?
BioCapInvest focuses on seed-stage investments in early-stage biopharmaceutical and digital health companies. The firm is particularly interested in technologies such as gene therapy, cell therapy, AI/ML-driven therapeutics, and digital health solutions.
How can I apply or pitch to BioCapInvest?
Founders can reach out to BioCapInvest via email at cyrus.chowdhury@biocapinvest.com. It is advisable to include a detailed pitch deck outlining the business model, technology, and market potential.
What makes BioCapInvest different from other venture capital firms?
BioCapInvest distinguishes itself through its exclusive focus on seed financing for life sciences innovations. The firm leverages the extensive experience of its founder, Cyrus A. Chowdhury, who has over 20 years in the life sciences sector, providing both capital and strategic guidance to portfolio companies.
What is the geographic scope of BioCapInvest's investments?
BioCapInvest primarily invests in companies based in the United States, focusing on innovations within the life sciences sector.
What is the typical check size for investments?
Specific check sizes have not been disclosed, but BioCapInvest specializes in seed-stage financing, which typically involves smaller initial investments to support early development.
What kind of post-investment involvement does BioCapInvest have?
BioCapInvest provides strategic guidance and connections within the healthcare ecosystem to help portfolio companies navigate the complexities of bringing their innovations to market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.